- Home
- VYGR vs ZTEK Comparison
VYGR vs ZTEK Comparison
Compare VYGR & ZTEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VYGR
- ZTEK
- Stock Information
- Founded
- VYGR 2013
- ZTEK 2008
- Country
- VYGR United States
- ZTEK Canada
- Employees
- VYGR N/A
- ZTEK N/A
- Industry
- VYGR Biotechnology: Pharmaceutical Preparations
- ZTEK Major Chemicals
- Sector
- VYGR Health Care
- ZTEK Industrials
- Exchange
- VYGR Nasdaq
- ZTEK Nasdaq
- Market Cap
- VYGR 156.0M
- ZTEK 165.9M
- IPO Year
- VYGR 2015
- ZTEK N/A
- Fundamental
- Price
- VYGR $2.97
- ZTEK $1.33
- Analyst Decision
- VYGR Strong Buy
- ZTEK
- Analyst Count
- VYGR 8
- ZTEK 0
- Target Price
- VYGR $14.33
- ZTEK N/A
- AVG Volume (30 Days)
- VYGR 841.7K
- ZTEK 29.1K
- Earning Date
- VYGR 08-05-2025
- ZTEK 08-13-2025
- Dividend Yield
- VYGR N/A
- ZTEK N/A
- EPS Growth
- VYGR N/A
- ZTEK N/A
- EPS
- VYGR N/A
- ZTEK N/A
- Revenue
- VYGR $66,958,000.00
- ZTEK $44,936.00
- Revenue This Year
- VYGR N/A
- ZTEK N/A
- Revenue Next Year
- VYGR $78.88
- ZTEK N/A
- P/E Ratio
- VYGR N/A
- ZTEK N/A
- Revenue Growth
- VYGR N/A
- ZTEK 92.38
- 52 Week Low
- VYGR $2.65
- ZTEK $0.50
- 52 Week High
- VYGR $9.55
- ZTEK $1.84
- Technical
- Relative Strength Index (RSI)
- VYGR 41.86
- ZTEK 36.79
- Support Level
- VYGR $3.24
- ZTEK $1.39
- Resistance Level
- VYGR $3.64
- ZTEK $1.55
- Average True Range (ATR)
- VYGR 0.27
- ZTEK 0.09
- MACD
- VYGR -0.02
- ZTEK -0.02
- Stochastic Oscillator
- VYGR 6.17
- ZTEK 2.04
About VYGR Voyager Therapeutics Inc.
Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.
About ZTEK Zentek Ltd.
Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection, and treatment. It is focused on commercializing ZENGuard, a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases.